Is Benadryl (diphenhydramine) a suitable treatment for allergic symptoms in a 19-month-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl Use in a 19-Month-Old Child

Diphenhydramine (Benadryl) should NOT be used for routine allergic symptoms in a 19-month-old child due to significant safety concerns, including 33 deaths in children under 6 years of age between 1969-2006, with the FDA and pediatric advisory committees explicitly recommending against its use in children below 6 years. 1

Why Diphenhydramine Should Be Avoided

  • The FDA drug label explicitly states "do not use to make a child sleepy" and diphenhydramine carries serious risks in young children. 2

  • Between 1969 and 2006, diphenhydramine was responsible for 33 of 69 total antihistamine-related deaths in children under 6 years of age, with 41 cases occurring in children under 2 years. 1

  • First-generation antihistamines like diphenhydramine cause significant sedation, cognitive impairment, and psychomotor effects that are particularly dangerous in young children. 3

  • Recent case reports document cardiac arrest in infants following intravenous diphenhydramine administration, highlighting its cardiovascular toxicity potential. 4

Recommended Safe Alternatives

Second-generation antihistamines are the appropriate first-line therapy for allergic symptoms in this age group:

  • Cetirizine 2.5 mg once or twice daily is recommended for children aged 2-5 years and has an excellent safety profile. 1

  • Loratadine 5 mg once daily is an alternative option for children aged 2-5 years. 1

  • Second-generation antihistamines (cetirizine, loratadine, desloratadine, fexofenadine, levocetirizine) have been extensively studied and shown to be well-tolerated with very good safety profiles in young children. 1

  • Liquid formulations are preferred in young children due to easier administration and better absorption. 1

The Only Exception: Anaphylaxis

Diphenhydramine may be used ONLY as adjunctive therapy in anaphylaxis, but never as first-line treatment:

  • Epinephrine is always the first-line treatment for anaphylaxis; diphenhydramine is purely adjunctive and should never substitute for epinephrine. 3

  • In anaphylaxis, diphenhydramine dosing is 1-2 mg/kg per dose (maximum 50 mg), with oral liquid absorbed more rapidly than tablets. 3

  • Diphenhydramine only relieves itching and urticaria in anaphylaxis; it does NOT relieve stridor, shortness of breath, wheezing, GI symptoms, or shock. 3

  • Even in anaphylaxis, second-generation antihistamines like cetirizine 10 mg may be used as an alternative with less sedation risk. 3

Clinical Algorithm for a 19-Month-Old with Allergic Symptoms

For mild allergic symptoms (few hives, mild itching, nasal symptoms):

  • Use cetirizine 2.5 mg once or twice daily 1
  • Avoid all OTC cough and cold combination products 1
  • Focus on identifying and avoiding triggers 1

For severe symptoms or suspected anaphylaxis (diffuse hives, respiratory symptoms, tongue/lip swelling, circulatory symptoms):

  • Administer epinephrine 0.15 mg IM immediately (for weight 10-25 kg) 3
  • Call 911 3
  • Diphenhydramine may be given as adjunctive therapy ONLY after epinephrine 3
  • Transport to emergency department for monitoring 3

Critical Safety Pitfall

The most dangerous pitfall is using diphenhydramine for routine allergic symptoms or as a sleep aid in young children—this practice has resulted in multiple pediatric deaths and is explicitly contraindicated by the FDA. 1, 2

References

Guideline

Antihistamine Dosing for Pediatric Allergic Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiac Arrest Following the Administration of Intravenous Diphenhydramine for Sedation to an Infant With Congenital Heart Disease.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.